BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 19639480)

  • 1. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
    Singh AP; Shah PP; Ruwali M; Mathur N; Pant MC; Parmar D
    Cancer Invest; 2009 Oct; 27(8):869-76. PubMed ID: 19639480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions.
    Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ
    Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
    Olshan AF; Weissler MC; Watson MA; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
    Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
    Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer.
    Gattás GJ; de Carvalho MB; Siraque MS; Curioni OA; Kohler P; Eluf-Neto J; Wünsch-Filho V
    Head Neck; 2006 Sep; 28(9):819-26. PubMed ID: 16721740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction.
    Maurya SS; Anand G; Dhawan A; Khan AJ; Jain SK; Pant MC; Parmar D
    Environ Mol Mutagen; 2014 Mar; 55(2):134-44. PubMed ID: 24519899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
    Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
    Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.
    Sam SS; Thomas V; Reddy SK; Surianarayanan G; Chandrasekaran A
    Head Neck; 2008 Dec; 30(12):1566-74. PubMed ID: 18767181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population.
    Soya SS; Vinod T; Reddy KS; Gopalakrishnan S; Adithan C
    Eur J Cancer; 2007 Dec; 43(18):2698-706. PubMed ID: 17707637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma.
    Peters ES; McClean MD; Marsit CJ; Luckett B; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2196-202. PubMed ID: 17119046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
    Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
    Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer.
    Oude Ophuis MB; Manni JJ; Peters WH
    Acta Otolaryngol; 2006 Mar; 126(3):311-7. PubMed ID: 16618661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
    Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
    Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer.
    Sabitha K; Reddy MV; Jamil K
    Cancer Epidemiol; 2010 Oct; 34(5):587-92. PubMed ID: 20887941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.